Latest Development Funding News

Patrys has assigned its deoxymab intellectual property to Yale University in a deal granting it half of all future commercialisation revenue, reducing capital needs while keeping long-term upside.

Sibelco Silica Pty Ltd has exercised its call option to inject an additional $4.4 million into the Diatreme joint venture, restoring ownership stakes and supporting key project milestones for the Northern Silica Project in Far North Queensland.

Taiko Critical Minerals has secured $7 million through a wholesale placement and launched a $3 million Share Purchase Plan to fund key development stages of its Barrytown Minerals Project, including feasibility studies and regulatory approvals.

Riversgold has been granted a 21-year mining lease for its Northern Zone Gold Project near Kalgoorlie, clearing a major hurdle for development and triggering full funding from Mega Resources under a profit-sharing agreement.

Australian Silica Quartz Group (ASQ) has finalized its acquisition of Australian Kaolin, gaining control of the White Swan Kaolin Project with a 47Mt inferred resource and an approved mining plan. The company raised $750,000 to advance development and is targeting export markets in Asia.

Strategic Elements has achieved a significant milestone with the granting of a patent in Japan for its Energy Ink™ moisture energy platform, reinforcing its foothold in a critical electronics market and advancing its battery-free device ambitions.

Sprintex Limited has locked in underwriting agreements covering 8.7 million unexercised options, potentially raising up to A$870,000. The company also agreed to extend a A$1.85 million convertible note maturity by one year, pending shareholder approval.

Calix's subsidiary Leilac has locked in a paid engineering study with an East Asian cement producer, advancing its commercial cement decarbonisation technology without capital outlay. This complements its recent Indian partnership and signals a strategic pivot to capital-light projects.

Right Resources has locked in a second tranche of A$755,000 in non-dilutive R&D funding for FY2026, boosting its collaboration with the University of Tasmania's CODES to deepen understanding of mineral systems in the Tumbarumba district.

Imagion Biosystems has raised $3.75 million to fund the start of its Phase 1b/2 clinical trial for the MagSense HER2 imaging agent in the US, following FDA clearance. The capital raising involves a two-tranche share placement with free attaching options, led by CPS Capital.

American West Metals is finalising its Pre-Feasibility Study for the Storm Copper Project in Nunavut, advancing permitting and exploration along a 110km copper belt, backed by secured development funding.

Canadian Phosphate (ASX: CP8) secured $5.2 million through a rights issue and follow-on placement, positioning itself to accelerate exploration and development across key projects in Canada and the US.